Literature DB >> 18158029

Age-specific prostate-specific antigen reference ranges in Korean men.

Young Deuk Choi1, Dae Ryong Kang, Chung Mo Nam, Young Sig Kim, Soung Yong Cho, Se Joong Kim, In Rae Cho, Jin Seon Cho, Sung Joon Hong, Won Sik Ham.   

Abstract

OBJECTIVES: The serum prostate-specific antigen (PSA) level varies widely among different races and increases with age. In this study, we evaluated the variation in serum PSA levels in a multicenter study population to determine a standard age-specific PSA reference range for Korean men without clinically evident prostate cancer.
METHODS: We retrospectively analyzed 120,439 Korean men, ranging in age from 30 to 79 years, whose serum PSA levels were measured at one of eight referral hospitals from November 1998 to July 2005.
RESULTS: Our recommended age-specific reference ranges (95th percentile) of serum PSA levels for Korean men were 0.32 to 1.88 ng/mL for men 30 to 39 years, 0.30 to 1.92 ng/mL for men 40 to 49 years, 0.30 to 2.37 ng/mL for men 50 to 59 years, 0.31 to 3.56 ng/mL for men 60 to 69 years, and 0.30 to 5.19 ng/mL for men 70 to 79 years old. The serum PSA level increased annually, corresponding to an increase of 0.0023 ng/mL for men in their 40s, 0.0175 ng/mL for men in their 50s, 0.0499 ng/mL for men in their 60s, and 0.0398 ng/mL for men in their 70s, with a steep increase for men in their 50s and the largest increase in men older than 60 years.
CONCLUSIONS: The results of our study have shown that the age-specific reference ranges (95th percentile) for serum PSA levels in Korean men are lower than those for white men. Our newly proposed age-specific reference ranges from this multicenter study will be more valuable in the interpretation of PSA data for Korean men.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18158029     DOI: 10.1016/j.urology.2007.07.063

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  10 in total

1.  Age-Specific Reference Ranges of Prostate-Specific Antigen among Saudi Men as a Representation of the Arab Population.

Authors:  Danny Munther Rabah; Karim Hamda Farhat; Mohamed Abdullah Al-Atawi; Mostafa Ahmed Arafa
Journal:  Med Princ Pract       Date:  2019-02-07       Impact factor: 1.927

2.  Body mass index and serum lipid profile influence serum prostate-specific antigen in Chinese men younger than 50 years of age.

Authors:  Ming Liu; Jian-Ye Wang; Ling Zhu; Gang Wan
Journal:  Asian J Androl       Date:  2010-12-20       Impact factor: 3.285

3.  Safety and efficacy of combined transrectal ultrasound-guided prostate needle biopsy and transurethral resection of the prostate.

Authors:  Jeong Man Cho; Seung Wook Lee; Jung Yoon Kang; Tag Keun Yoo
Journal:  Korean J Urol       Date:  2010-02-18

4.  A comparison of prostate cancer detection rates by 12 or 6 core biopsy at different prostate-specific antigen densities in Korean men.

Authors:  Hyeon Jeong; Byong Chang Jeong; Cheol Kwak; Eunsik Lee; Sang Eun Lee; Tae Beom Kim
Journal:  World J Urol       Date:  2008-04-26       Impact factor: 4.226

5.  Optimal baseline prostate-specific antigen level to distinguish risk of prostate cancer in healthy men between 40 and 69 years of age.

Authors:  Kyung Kgi Park; Seung Hwan Lee; Young Deuk Choi; Byung Ha Chung
Journal:  J Korean Med Sci       Date:  2011-12-19       Impact factor: 2.153

6.  Prostate cancer in Asia: A collaborative report.

Authors:  Rui Chen; Shancheng Ren; Ming Kwong Yiu; Ng Chi Fai; Wai Sam Cheng; Lap Hong Ian; Seiji Naito; Tadashi Matsuda; Elijah Kehinde; Ali Kural; Jason Yichun Chiu; Rainy Umbas; Qiang Wei; Xiaolei Shi; Liqun Zhou; Jian Huang; Yiran Huang; Liping Xie; Lulin Ma; Changjun Yin; Danfeng Xu; Kexin Xu; Zhangqun Ye; Chunxiao Liu; Dingwei Ye; Xin Gao; Qiang Fu; Jianquan Hou; Jianlin Yuan; Dalin He; Tiejun Pan; Qiang Ding; Fengshuo Jin; Benkang Shi; Gongxian Wang; Xiuheng Liu; Dongwen Wang; Zhoujun Shen; Xiangbo Kong; Wanhai Xu; Yaoliang Deng; Haibo Xia; Alexa N Cohen; Xu Gao; Chuanliang Xu; Yinghao Sun
Journal:  Asian J Urol       Date:  2015-04-16

7.  Post hoc analyses of East Asian patients from the randomized placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer.

Authors:  Choung Soo Kim; Young Deuk Choi; Sang Eun Lee; Hyun Moo Lee; Takeshi Ueda; Junji Yonese; Takashi Fukagai; Edmund Chiong; Weber Lau; Sarang Abhyankar; Ad Theeuwes; Bertrand Tombal; Tomasz M Beer; Go Kimura
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

8.  On the information hidden in a classifier distribution.

Authors:  Farrokh Habibzadeh; Parham Habibzadeh; Mahboobeh Yadollahie; Hooman Roozbehi
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

9.  Age-specific reference ranges of prostate-specific antigen in the elderly of Amirkola: A population-based study.

Authors:  Hosseini Seyed Reza; Zabihi Ali; Habibian Tara; Bijani Ali
Journal:  Asian J Urol       Date:  2020-03-07

10.  Practice patterns of Korean urologists for screening and managing prostate cancer according to PSA level.

Authors:  Mun Su Chung; Seung Hwan Lee; Dong Hoon Lee; Se Joong Kim; Choung Soo Kim; Kyu Sung Lee; Jae Il Jung; Sae Woong Kim; Yil Seob Lee; Byung Ha Chung
Journal:  Yonsei Med J       Date:  2012-11-01       Impact factor: 2.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.